Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
12/14/1999 | US6001799 Method of treating hepatitis C in non-responders to interferon treatment |
12/14/1999 | US6001647 In vitro growth of functional islets of Langerhans and in vivo uses thereof |
12/14/1999 | US6001601 Methionyl tRNA synthetase polynucleotides |
12/14/1999 | US6001557 Polycation conjugate coding defective virus which reduces the packaging efficiency virus, a minigene and sequences which allow for efficiect viral infection; for gene therapy |
12/14/1999 | US6001387 Spin disk encapsulation apparatus and method of use |
12/14/1999 | US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis |
12/14/1999 | US6001360 Glutamic acid decarboxylase (gad) proteins and fragments thereof are administered to an animal in order to the reduce the severity of diabetes |
12/14/1999 | US6001352 Contacting condrocytes with specific platelet-derived growth factors (pdgf) in the absence of growth factors which promote cell differentiation; cells cultured and loaded onto scaffolding for implanting into a cartilage or bone wound |
12/14/1999 | US6001351 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
12/14/1999 | US6001349 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof |
12/14/1999 | US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae |
12/14/1999 | US6001312 Reactor for making uniform capsules |
12/14/1999 | US6001259 Preparation of autologous plasma and fibrin gel |
12/14/1999 | CA2186526C Method and product for regulating cell responsiveness to external signals |
12/14/1999 | CA2155024C Genetic modification of neural stem cells |
12/14/1999 | CA1340852C Process for purifying primate gm-csf protein |
12/09/1999 | WO1999063101A2 Transfected cells and methods for treating diabetes |
12/09/1999 | WO1999063050A2 Method for preparation and in vivo administration of antigen presenting cell composition |
12/09/1999 | WO1999062561A2 Gene therapy method |
12/09/1999 | WO1999062558A1 Insulin supplemented infant formula |
12/09/1999 | WO1999062527A1 nrdE |
12/09/1999 | WO1999062473A1 Use of micro-organism extracts in cosmetic or pharmaceutical compositions |
12/09/1999 | WO1999062451A1 Topical transdermal treatments |
12/09/1999 | WO1999051275A3 Mesenchymal stem cells as immunosuppressants |
12/09/1999 | WO1999048506A3 Composition containing at least one metal yeast for pharmaceutical use and/or for use as a nutrition supplement, for humans or animals |
12/09/1999 | WO1999046367A3 Methods of diagnosis and triage using cell activation measures |
12/09/1999 | WO1999044943A3 Vectors and viruses used in gene therapy |
12/09/1999 | WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
12/09/1999 | DE19825620A1 Verwendung von adenoassoziierten Viren zur Senkung der radio- oder chemotherapieinduzierten Resistenz bei Krebspatienten Adeno-associated viruses use to reduce radio- or chemotherapy-induced resistance in cancer patients |
12/09/1999 | DE19825419A1 Production of high porosity solid useful as bone substitute |
12/09/1999 | CA2334171A1 Gene therapy method |
12/09/1999 | CA2333903A1 Topical transdermal treatments |
12/09/1999 | CA2330027A1 Method for preparation and in vivo administration of antigen presenting cell composition |
12/08/1999 | EP0961780A1 Protein markers for lung cancer and use thereof |
12/08/1999 | EP0634934B1 Use of dietary whey proteins for the treatment of hiv-seropositive individuals |
12/08/1999 | EP0522078B1 Gp75 as a tumor vaccine for melanoma |
12/08/1999 | CN1237909A Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
12/08/1999 | CN1237881A Method and compositions for increasing anaerobic working capacity in tissues |
12/08/1999 | CN1237451A Enema liquor for woman pelvic inflammation |
12/08/1999 | CN1237429A Medicine for curing tumor and its preparation method |
12/08/1999 | CN1237427A Adhesive plaster for curing prolapse of lumbar intervertebral disk |
12/08/1999 | CN1237422A Preparation process of insect protein capsule or powder |
12/08/1999 | CN1237421A Preparation method of liquid donkey-hide gelatin by zymohydrolysis |
12/08/1999 | CN1047203C Enzymolytic hydrolytic ovalbumin solution and its preparing method and use |
12/08/1999 | CN1047086C Poultry antibiotic Chinese patent drug and its preparing method |
12/08/1999 | CN1047085C Medicine for curing syphilis and gonorrhoea, and its preparing method |
12/07/1999 | US5998587 Anti-cyanovirin antibody |
12/07/1999 | US5998205 Vectors for tissue-specific replication |
12/07/1999 | US5998192 For use in many human gene therapy protocols, especially those requiring transduction of normal or neoplastic haemopoietic cells. |
12/07/1999 | US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained |
12/07/1999 | US5997909 Composition containing a complex of a polyvalent metal and a DNA-sodium salt |
12/07/1999 | US5997908 Prostate extract supplemented with zinc |
12/07/1999 | US5997900 High viscosity sodium alginate, cellulose sulfate, and poly(methylene-co-guanidine)hydrochloride, calcium chloride or sodium chloride. |
12/07/1999 | US5997885 Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging |
12/07/1999 | US5997880 Method for alleviating varicella related post-herpetic neuralgia |
12/07/1999 | US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses |
12/07/1999 | US5997870 Isolated peptides which bind to HLA-B44 Molecules |
12/07/1999 | CA2155928C Plastic articles of reduced gas transmission and method therefor |
12/07/1999 | CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity |
12/02/1999 | WO1999061645A1 Novel compound, wf00144 |
12/02/1999 | WO1999061639A2 Retroviral delivery system |
12/02/1999 | WO1999061638A1 Chimeric adenoviral vectors |
12/02/1999 | WO1999061636A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region |
12/02/1999 | WO1999061625A1 Mycobacterial n-acetyltransferases |
12/02/1999 | WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
12/02/1999 | WO1999061595A2 Adeno-associated viral vector-mediated expression of factor viii activity |
12/02/1999 | WO1999061589A2 Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof |
12/02/1999 | WO1999061588A1 Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
12/02/1999 | WO1999061587A1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
12/02/1999 | WO1999061586A1 Promotion of cell differentiation by initially passaged cells |
12/02/1999 | WO1999061584A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
12/02/1999 | WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein |
12/02/1999 | WO1999061085A2 Method and compositions for treatment of cancers |
12/02/1999 | WO1999061066A2 Convection-enhanced delivery of aav vectors |
12/02/1999 | WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors |
12/02/1999 | WO1999061052A2 Oral immunization with papillomavirus virus-like particles |
12/02/1999 | WO1999061035A1 Preparation based on the artichoke plant, especially for use as a medicament or food supplement |
12/02/1999 | WO1999061011A2 Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections |
12/02/1999 | WO1999060951A1 Compositions for regenerating tissue that has degenerated, and methods for using such compositions |
12/02/1999 | WO1999060846A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies |
12/02/1999 | WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases |
12/02/1999 | WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily |
12/02/1999 | WO1999046381A9 Human fgf gene and gene expression products |
12/02/1999 | WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same |
12/02/1999 | WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
12/02/1999 | DE19823318A1 Verwendung eines Arzneimittels mit einem Gehalt an Tyrothricin zur Behandlung von Virusinfektionen Use of a pharmaceutical having a content of tyrothricin for the treatment of viral infections |
12/02/1999 | CA2333702A1 Promotion of cell differentiation by initially passaged cells |
12/02/1999 | CA2332336A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies |
12/02/1999 | CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity |
12/02/1999 | CA2329136A1 Oral immunization with papillomavirus virus-like particles |
12/02/1999 | CA2328524A1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
12/02/1999 | CA2328491A1 Retroviral delivery system |
12/02/1999 | CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
12/02/1999 | CA2328425A1 Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
12/02/1999 | CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein |
12/02/1999 | CA2298064A1 Chimeric adenoviral vectors |
12/01/1999 | EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE |
12/01/1999 | EP0959903A1 NOVEL FabD |
12/01/1999 | EP0959892A1 Use of pvp or povidone for reducing bowel distension |
12/01/1999 | EP0822845A4 Systems and methods for on-line finishing of cellular blood products like platelets harvested for therapeutic purposes |